Table 3.
Target | Wild type | Rev1B/B | |
---|---|---|---|
Mutations at dipyrimidine sites | |||
Single base pair substitutions | 45 | 20 | |
Transitions | |||
GC > AT | CCTa | 11 | 6 |
TCCa | 10 | 6 | |
CT | 2 | 1 | |
CC | 3 | 4 | |
TC | 3 | 3 | |
AT > GC | CTTa | 2 | 0 |
TC | 1 | 0 | |
Transversions | |||
GC > TA | TC | 1 | 0 |
TCCa | 1 | 0 | |
AT > CG | CTTa | 1 | 0 |
AT > TA | TT | 10 | 0 |
Double base pair substitutions | 5 | 6 | |
Mutations at non-dipyrimidine sites | |||
Single base pair substitutions | 0 | 3 | |
Transversions | |||
GC > TA | 0 | 1 | |
AT > CG | 0 | 1 | |
AT > TA | 0 | 1 | |
Double base pair substitutions | 1 | 1 | |
Othersb | 30 | 40 |
aMutations present in tripyrimidine sequences do not allow to define the dimer site of the UV-C-induced lesion.
bMutants that either display a frameshift, lack one or more exons in the Hprt mRNA, express no Hprt mRNA or contain no mutation in the coding region.